BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, Salehi R, Sadeghi B, Manian M. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 2021;21:62. [PMID: 33472628 DOI: 10.1186/s12935-020-01719-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 95] [Article Influence: 40.0] [Reference Citation Analysis]
Number Citing Articles
1 Zeng L, Zhu Y, Moreno CS, Wan Y. New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy. Semin Cancer Biol 2023;90:29-44. [PMID: 36806560 DOI: 10.1016/j.semcancer.2023.02.003] [Reference Citation Analysis]
2 Fernandes PD, Magalhães FD, Pereira RF, Pinto AM. Metal-Organic Frameworks Applications in Synergistic Cancer Photo-Immunotherapy. Polymers 2023;15:1490. [DOI: 10.3390/polym15061490] [Reference Citation Analysis]
3 Nirmala MJ, Kizhuveetil U, Johnson A, G B, Nagarajan R, Muthuvijayan V. Cancer nanomedicine: a review of nano-therapeutics and challenges ahead. RSC Adv 2023;13:8606-29. [PMID: 36926304 DOI: 10.1039/d2ra07863e] [Reference Citation Analysis]
4 Kumari S, Kumar P. Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme. ACS Omega 2023. [DOI: 10.1021/acsomega.3c00441] [Reference Citation Analysis]
5 Artusa V, Calabrone L, Mortara L, Peri F, Bruno A. Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory. Int J Mol Sci 2023;24. [PMID: 36902427 DOI: 10.3390/ijms24054997] [Reference Citation Analysis]
6 Ma C, Zhou Y, Fanelli GN, Stopsack KH, Fiorentino M, Zadra G, Mucci LA, Loda M, Tyekucheva S, Penney KL. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer. Mol Cancer Res 2023;21:253-60. [PMID: 36511902 DOI: 10.1158/1541-7786.MCR-22-0627] [Reference Citation Analysis]
7 Alabrahim OAA, Fahmy SA, Azzazy HME. Stimuli-Responsive Cucurbit[n]uril-Based Supramolecular Nanocarriers for Delivery of Chemotherapeutics. ACS Appl Nano Mater 2023. [DOI: 10.1021/acsanm.2c05391] [Reference Citation Analysis]
8 Aboukhatwa SM, Sidhom PA, Angeli A, Supuran CT, Tawfik HO. Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids. ACS Omega 2023;8:7666-83. [PMID: 36872984 DOI: 10.1021/acsomega.2c07285] [Reference Citation Analysis]
9 Shou Y, Teo XY, Li X, Zhicheng L, Liu L, Sun X, Jonhson W, Ding J, Lim CT, Tay A. Dynamic Magneto-Softening of 3D Hydrogel Reverses Malignant Transformation of Cancer Cells and Enhances Drug Efficacy. ACS Nano 2023;17:2851-67. [PMID: 36633150 DOI: 10.1021/acsnano.2c11278] [Reference Citation Analysis]
10 Flores-Torres S, Jiang T, Kort-Mascort J, Yang Y, Peza-Chavez O, Pal S, Mainolfi A, Pardo LA, Ferri L, Bertos N, Sangwan V, Kinsella JM. Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based Bioprinting. ACS Biomater Sci Eng 2023;9:542-61. [PMID: 36598339 DOI: 10.1021/acsbiomaterials.2c00998] [Reference Citation Analysis]
11 Malagoli Tagliazucchi G, Wiecek AJ, Withnell E, Secrier M. Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. Nat Commun 2023;14:789. [PMID: 36774358 DOI: 10.1038/s41467-023-36439-7] [Reference Citation Analysis]
12 Nguyen TMH, Lai YS, Chen YC, Lin TC, Nguyen NT, Chiu WT. Hypoxia-induced YAP activation and focal adhesion turnover to promote cell migration in mesenchymal TNBC cells. Cancer Med 2023. [PMID: 36757143 DOI: 10.1002/cam4.5680] [Reference Citation Analysis]
13 Ozcan G. The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting. Front Cell Dev Biol 2023;11:1082057. [PMID: 36846589 DOI: 10.3389/fcell.2023.1082057] [Reference Citation Analysis]
14 Li W, Li R, Ye Q, Zou Y, Lu X, Zhang W, Chen J, Zhao Y. Mn(3) O(4) Nanoshell Coated Metal-Organic Frameworks with Microenvironment-Driven O(2) Production and GSH Exhaustion Ability for Enhanced Chemodynamic and Photodynamic Cancer Therapies. Adv Healthc Mater 2023;:e2202280. [PMID: 36753620 DOI: 10.1002/adhm.202202280] [Reference Citation Analysis]
15 Han HH, Wang HM, Jangili P, Li M, Wu L, Zang Y, Sedgwick AC, Li J, He XP, James TD, Kim JS. The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy. Chem Soc Rev 2023;52:879-920. [PMID: 36637396 DOI: 10.1039/d2cs00673a] [Reference Citation Analysis]
16 Yoshida S, Hamada Y, Narita M, Sato D, Tanaka K, Mori T, Tezuka H, Suda Y, Tamura H, Aoki K, Kuzumaki N, Narita M. Elucidation of the mechanisms underlying tumor aggravation by the activation of stress-related neurons in the paraventricular nucleus of the hypothalamus. Mol Brain 2023;16:18. [PMID: 36732798 DOI: 10.1186/s13041-023-01006-0] [Reference Citation Analysis]
17 Saber S, El-Fattah EEA, Abdelhamid AM, Mourad AAE, Hamouda MAM, Elrabat A, Zakaria S, Haleem AA, Mohamed SZ, Elgharabawy RM, Morsy NE, El Adle Khalaf N, Mohammed OA, El-Bahouty WB, Mostafa SA, Abdelhady R, Galal O, ElSaid ZH, Yahya G, Shata A, Youssef ME. Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling. Biomed Pharmacother 2023;158:114196. [PMID: 36916405 DOI: 10.1016/j.biopha.2022.114196] [Reference Citation Analysis]
18 Zhang S, Li Y, Dong R, Li W, Qian Z, Yang Y. All-in-one device for mapping the interactive effects of photodynamic therapy dosimetry in tumor gaseous microenvironment. J Photochem Photobiol B 2023;239:112645. [PMID: 36608400 DOI: 10.1016/j.jphotobiol.2022.112645] [Reference Citation Analysis]
19 Price JM, Prabhakaran A, West CML. Predicting tumour radiosensitivity to deliver precision radiotherapy. Nat Rev Clin Oncol 2023;20:83-98. [PMID: 36477705 DOI: 10.1038/s41571-022-00709-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sun K, Li X, Scherer PE. Extracellular Matrix (ECM) and Fibrosis in Adipose Tissue: Overview and Perspectives. Compr Physiol 2023;13:4387-407. [PMID: 36715281 DOI: 10.1002/cphy.c220020] [Reference Citation Analysis]
21 Sekar R, Basavegowda N, Thathapudi JJ, Sekhar MR, Joshi P, Somu P, Baek KH. Recent Progress of Gold-Based Nanostructures towards Future Emblem of Photo-Triggered Cancer Theranostics: A Special Focus on Combinatorial Phototherapies. Pharmaceutics 2023;15. [PMID: 36839754 DOI: 10.3390/pharmaceutics15020433] [Reference Citation Analysis]
22 Bridges HR, Blaza JN, Yin Z, Chung I, Pollak MN, Hirst J. Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides. Science 2023;379:351-7. [PMID: 36701435 DOI: 10.1126/science.ade3332] [Reference Citation Analysis]
23 Nushtaeva A, Ermakov M, Abdurakhmanova M, Troitskaya O, Belovezhets T, Varlamov M, Gayner T, Richter V, Koval O. "Pulsed Hypoxia" Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal-Epithelial Transition. Int J Mol Sci 2023;24. [PMID: 36768815 DOI: 10.3390/ijms24032494] [Reference Citation Analysis]
24 Xiao CL, Zhong ZP, Lü C, Guo BJ, Chen JJ, Zhao T, Yin ZF, Li B. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. J Integr Med 2023:S2095-4964(23)00002-X. [PMID: 36781361 DOI: 10.1016/j.joim.2023.01.002] [Reference Citation Analysis]
25 Kim M, Bakyt L, Akhmetkaliyev A, Toktarkhanova D, Bulanin D. Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents. Int J Mol Sci 2023;24. [PMID: 36768445 DOI: 10.3390/ijms24032122] [Reference Citation Analysis]
26 Garcia-Becerra N, Aguila-Estrada MU, Palafox-Mariscal LA, Hernandez-Flores G, Aguilar-Lemarroy A, Jave-Suarez LF. FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes. Cancers (Basel) 2023;15. [PMID: 36672296 DOI: 10.3390/cancers15020347] [Reference Citation Analysis]
27 García-Chico C, López-Ortiz S, Peñín-Grandes S, Pinto-Fraga J, Valenzuela PL, Emanuele E, Ceci C, Graziani G, Fiuza-Luces C, Lista S, Lucia A, Santos-Lozano A. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review. Cancers (Basel) 2023;15. [PMID: 36612320 DOI: 10.3390/cancers15010324] [Reference Citation Analysis]
28 He L, Wang J, Zhu P, Chen J, Zhao S, Liu X, Li Y, Guo X, Yan Z, Shen X, Li C. Intelligent manganese dioxide nanocomposites induce tumor immunogenic cell death and remould tumor microenvironment. Chemical Engineering Journal 2023. [DOI: 10.1016/j.cej.2023.141369] [Reference Citation Analysis]
29 Tang JLY, Moonshi SS, Ta HT. Nanoceria: an innovative strategy for cancer treatment. Cell Mol Life Sci 2023;80:46. [PMID: 36656411 DOI: 10.1007/s00018-023-04694-y] [Reference Citation Analysis]
30 Rad HS, Shiravand Y, Radfar P, Ladwa R, Warkiani ME, O’byrne K, Kulasinghe A. Spatial Transcriptomic Approaches for Understanding the Tumor Microenvironment (TME). Interdisciplinary Cancer Research 2023. [DOI: 10.1007/16833_2022_111] [Reference Citation Analysis]
31 Wang X, Sun J, Li J, Cai L, Chen Q, Wang Y, Yang Z, Liu W, Lv H, Wang Z. Bidirectional Mendelian randomization study of insulin-related traits and risk of ovarian cancer. Front Endocrinol (Lausanne) 2023;14:1131767. [PMID: 36936171 DOI: 10.3389/fendo.2023.1131767] [Reference Citation Analysis]
32 Zaher NH, Elhazek RM, Gouda AE, Khalil A, Elgazzar MG. Challenging breast cancer through novel sulfonamide-pyridine hybrids: design, synthesis, carbonic anhydrase IX inhibition and induction of apoptosis. Future Med Chem 2023;15:147-66. [PMID: 36762576 DOI: 10.4155/fmc-2022-0197] [Reference Citation Analysis]
33 Momtazmanesh S, Rezaei N. Introduction to Tumor Microenvironment. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_82-1] [Reference Citation Analysis]
34 Smith PJ, McKeown SR, Patterson LH. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). IUBMB Life 2023;75:40-54. [PMID: 35499745 DOI: 10.1002/iub.2619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pal K, Sheth RA. Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions. Cancers (Basel) 2022;15. [PMID: 36612192 DOI: 10.3390/cancers15010196] [Reference Citation Analysis]
36 Paul SK, Dutta Chowdhury K, Dey SR, Paul A, Haldar R. Exploring the possibility of drug repurposing for cancer therapy targeting human lactate dehydrogenase A: a computational approach. J Biomol Struct Dyn 2022;:1-10. [PMID: 36576127 DOI: 10.1080/07391102.2022.2158134] [Reference Citation Analysis]
37 Kazama R, Fujita S, Sakai S. Cell Dome as an Evaluation Platform for Organized HepG2 Cells. Cells 2022;12. [PMID: 36611862 DOI: 10.3390/cells12010069] [Reference Citation Analysis]
38 Correnti M, Binatti E, Gammella E, Invernizzi P, Recalcati S. The Emerging Role of Tumor Microenvironmental Stimuli in Regulating Metabolic Rewiring of Liver Cancer Stem Cells. Cancers (Basel) 2022;15. [PMID: 36612000 DOI: 10.3390/cancers15010005] [Reference Citation Analysis]
39 Dittmar T, Hass R. Extracellular Events Involved in Cancer Cell-Cell Fusion. Int J Mol Sci 2022;23. [PMID: 36555709 DOI: 10.3390/ijms232416071] [Reference Citation Analysis]
40 Zhang H, Wan GZ, Wang YY, Chen W, Guan JZ. The role of erythrocytes and erythroid progenitor cells in tumors. Open Life Sci 2022;17:1641-56. [PMID: 36567722 DOI: 10.1515/biol-2022-0102] [Reference Citation Analysis]
41 Orasanu CI, Aschie M, Deacu M, Bosoteanu M, Vamesu S, Enciu M, Bălţătescu GI, Cozaru GC, Mitroi AF, Voda RI. Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type. Clin Pract 2022;12:1054-68. [PMID: 36547116 DOI: 10.3390/clinpract12060108] [Reference Citation Analysis]
42 D’accardo C, Porcelli G, Mangiapane LR, Modica C, Pantina VD, Roozafzay N, Di Franco S, Gaggianesi M, Veschi V, Lo Iacono M, Todaro M, Turdo A, Stassi G. Cancer cell targeting by CAR-T cells: A matter of stemness. Front Mol Med 2022;2. [DOI: 10.3389/fmmed.2022.1055028] [Reference Citation Analysis]
43 Adebayo AK, Nakshatri H. Modeling Preclinical Cancer Studies under Physioxia to Enhance Clinical Translation. Cancer Res 2022;82:4313-21. [PMID: 36169928 DOI: 10.1158/0008-5472.CAN-22-2311] [Reference Citation Analysis]
44 Papadaki S, Magklara A. Regulation of Metabolic Plasticity in Cancer Stem Cells and Implications in Cancer Therapy. Cancers (Basel) 2022;14. [PMID: 36497394 DOI: 10.3390/cancers14235912] [Reference Citation Analysis]
45 Mahmudi H, Adili-aghdam MA, Shahpouri M, Jaymand M, Amoozgar Z, Jahanban-esfahlan R. Tumor microenvironment penetrating chitosan nanoparticles for elimination of cancer relapse and minimal residual disease. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1054029] [Reference Citation Analysis]
46 Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J, Hassan MI, Islam A. Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches. Pharmaceutics 2022;14. [PMID: 36559149 DOI: 10.3390/pharmaceutics14122657] [Reference Citation Analysis]
47 Pebam M, P S R, Gangopadhyay M, Thatikonda S, Rengan AK. Terminalia chebula Polyphenol and Near-Infrared Dye-Loaded Poly(lactic acid) Nanoparticles for Imaging and Photothermal Therapy of Cancer Cells. ACS Appl Bio Mater 2022;5:5333-46. [PMID: 36288561 DOI: 10.1021/acsabm.2c00724] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Yoon JS, Lee CW. Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma. Exp Mol Med 2022;54:1799-813. [PMID: 36380016 DOI: 10.1038/s12276-022-00883-0] [Reference Citation Analysis]
49 Li S, Man Q, Liu B. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.943945] [Reference Citation Analysis]
50 Sonawala K, Ramalingam S, Sellamuthu I. Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways. Cells 2022;11:3492. [DOI: 10.3390/cells11213492] [Reference Citation Analysis]
51 Leontyev AV, Khodzhibekova MM, Khalimon AI, Kuliev MT, Khamadeeva GF, Antonevskaya TL, Lazutina TN, Kaprin AD. <sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya 2022;12:444-454. [DOI: 10.30895/1991-2919-2022-12-4-444-454] [Reference Citation Analysis]
52 Ansarinik Z, Kiyani H, Yoosefian M. Investigation of self-assembled poly(ethylene glycol)-poly(L-lactic acid) micelle as potential drug delivery system for poorly water soluble anticancer drug abemaciclib. Journal of Molecular Liquids 2022;365:120192. [DOI: 10.1016/j.molliq.2022.120192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Ma XY, Hill BD, Hoang T, Wen F. Virus-inspired strategies for cancer therapy. Semin Cancer Biol 2022;86:1143-57. [PMID: 34182141 DOI: 10.1016/j.semcancer.2021.06.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
54 Queen A, Bhutto HN, Yousuf M, Syed MA, Hassan MI. Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation. Semin Cancer Biol 2022;86:899-913. [PMID: 34998944 DOI: 10.1016/j.semcancer.2022.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
55 Oo MW, Kawai H, Eain HS, Soe Y, Takabatake K, Sanou S, Shan Q, Inada Y, Fujii M, Fukuhara Y, Wang Z, Sukegawa S, Ono M, Nakano K, Nagatsuka H. SOD3 Expression in Tumor Stroma Provides the Tumor Vessel Maturity in Oral Squamous Cell Carcinoma. Biomedicines 2022;10:2729. [DOI: 10.3390/biomedicines10112729] [Reference Citation Analysis]
56 Ruiz M, Zhang N, Sood AK, An Z. Antibody therapeutics for epithelial ovarian cancer. Expert Opinion on Biological Therapy 2022. [DOI: 10.1080/14712598.2022.2141565] [Reference Citation Analysis]
57 Pęczek P, Gajda M, Rutkowski K, Fudalej M, Deptała A, Badowska-Kozakiewicz AM. Cancer-associated inflammation: pathophysiology and clinical significance. J Cancer Res Clin Oncol 2022. [PMID: 36260158 DOI: 10.1007/s00432-022-04399-y] [Reference Citation Analysis]
58 Shi Y, Gao Q, Liu Z, Shen G, Sun X, Di X, Cao S. Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer. Journal of Oncology 2022;2022:1-20. [DOI: 10.1155/2022/6906380] [Reference Citation Analysis]
59 Zhang S, Zhou J, Shang P, Zhao G, Wang A, Mao J, Tao Y, Chen Z, Wang X, Guo C. SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses. Exp Mol Med 2022;54:1741-55. [PMID: 36224346 DOI: 10.1038/s12276-022-00867-0] [Reference Citation Analysis]
60 Jacquet P, Stéphanou A. Searching for the Metabolic Signature of Cancer: A Review from Warburg's Time to Now. Biomolecules 2022;12:1412. [PMID: 36291621 DOI: 10.3390/biom12101412] [Reference Citation Analysis]
61 Zaffaroni M, Vincini MG, Corrao G, Marvaso G, Pepa M, Viglietto G, Amodio N, Jereczek-fossa BA. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy. IJMS 2022;23:11343. [DOI: 10.3390/ijms231911343] [Reference Citation Analysis]
62 Gomez RL, Ibragimova S, Ramachandran R, Philpott A, Ali FR. Tumoral heterogeneity in neuroblastoma. Biochim Biophys Acta Rev Cancer 2022;1877:188805. [PMID: 36162542 DOI: 10.1016/j.bbcan.2022.188805] [Reference Citation Analysis]
63 Liu X, Zeng S, Zhang M, Jiang M, Kafuti YS, Shangguan P, Yu Y, Chen Q, Wang J, Peng X, Yoon J, Li H. Monitoring mitochondrial nitroreductase activity in tumors and a hind-limb model of ischemia in mice using a novel activatable NIR fluorescent probe. Chem Commun (Camb) 2022. [PMID: 36135099 DOI: 10.1039/d2cc04112j] [Reference Citation Analysis]
64 García-caballero M, Sokol L, Cuypers A, Carmeliet P. Metabolic Reprogramming in Tumor Endothelial Cells. IJMS 2022;23:11052. [DOI: 10.3390/ijms231911052] [Reference Citation Analysis]
65 Didamson OC, Chandran R, Abrahamse H. A Gold Nanoparticle Bioconjugate Delivery System for Active Targeted Photodynamic Therapy of Cancer and Cancer Stem Cells. Cancers 2022;14:4558. [DOI: 10.3390/cancers14194558] [Reference Citation Analysis]
66 Mukherjee AG, Wanjari UR, Namachivayam A, Murali R, Prabakaran DS, Ganesan R, Renu K, Dey A, Vellingiri B, Ramanathan G, Doss C. GP, Gopalakrishnan AV. Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach. Vaccines 2022;10:1493. [DOI: 10.3390/vaccines10091493] [Reference Citation Analysis]
67 Kim JH, Park JM, Jung E, Lee J, Han J, Kim YJ, Kim JY, Seo JH, Kim JS. A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasis. Biomaterials 2022;289:121781. [PMID: 36113331 DOI: 10.1016/j.biomaterials.2022.121781] [Reference Citation Analysis]
68 Saha D, Mitra D, Alam N, Sen S, Mustafi SM, Majumder PK, Majumder B, Murmu N. Lupeol and Paclitaxel cooperate in hindering hypoxia induced vasculogenic mimicry via suppression of HIF-1α-EphA2-Laminin-5γ2 network in human oral cancer. J Cell Commun Signal 2022. [PMID: 36063341 DOI: 10.1007/s12079-022-00693-z] [Reference Citation Analysis]
69 Fourie C, du Plessis M, Mills J, Engelbrecht AM. The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia. Exp Cell Res 2022;:113334. [PMID: 36044939 DOI: 10.1016/j.yexcr.2022.113334] [Reference Citation Analysis]
70 Soner BC, Açikgöz E, Duzagac F, Parlayan C. Expression of the Low-density Lipoprotein Receptor (LDLR) Gene Family in CD133+/CD44+ Prostate Cancer Stem Cells. JBACHS 2022. [DOI: 10.30621/jbachs.1140895] [Reference Citation Analysis]
71 Rocha JD, Uribe D, Delgado J, Niechi I, Alarcón S, Erices JI, Melo R, Fernández-Gajardo R, Salazar-Onfray F, San Martín R, Quezada Monrás C. A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function. Int J Mol Sci 2022;23:9022. [PMID: 36012307 DOI: 10.3390/ijms23169022] [Reference Citation Analysis]
72 Bridges HR, Blaza JN, Yin Z, Chung I, Pollak MN, Hirst J. Structural Basis of Mammalian Respiratory Complex I Inhibition by Medicinal Biguanides.. [DOI: 10.1101/2022.08.09.503333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Chang YH, Vuong CK, Ngo NH, Yamashita T, Ye X, Futamura Y, Fukushige M, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Sakurai T, Ohneda O. Extracellular vesicles derived from Wharton's Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway. Sci Rep 2022;12:13550. [PMID: 35941273 DOI: 10.1038/s41598-022-17767-y] [Reference Citation Analysis]
74 Sun H, Qi X. The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00536-8] [Reference Citation Analysis]
75 Ali Khadem Z, Abdul Wadood Al-Shammaree S. Prognostic Value of Intracellular Transcription of Factors HIF-1α and p53 and Their Relation to Estradiol and TNM Parameters of Breast Cancer Tissues in Women with Invasive Ductal Carcinoma in Thi-Qar Province, Iraq. Arch Razi Inst 2022;77:1341-8. [PMID: 36883155 DOI: 10.22092/ARI.2022.357640.2080] [Reference Citation Analysis]
76 D. Radosavljevic G, Pantic J, Simovic Markovic B, Arsenijevic N. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling. Tumor Angiogenesis and Modulators 2022. [DOI: 10.5772/intechopen.102893] [Reference Citation Analysis]
77 Hussen BM, Kheder RK, Abdullah ST, Hidayat HJ, Rahman HS, Salihi A, Taheri M, Ghafouri-Fard S. Functional interplay between long non-coding RNAs and Breast CSCs. Cancer Cell Int 2022;22:233. [PMID: 35864503 DOI: 10.1186/s12935-022-02653-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
78 Zhang Y, Boley D. Nonlinear multi-objective flux balance analysis of the Warburg Effect. J Theor Biol 2022;550:111223. [PMID: 35853493 DOI: 10.1016/j.jtbi.2022.111223] [Reference Citation Analysis]
79 Manzoor S, Muhammad JS, Maghazachi AA, Hamid Q. Autophagy: A Versatile Player in the Progression of Colorectal Cancer and Drug Resistance. Front Oncol 2022;12:924290. [DOI: 10.3389/fonc.2022.924290] [Reference Citation Analysis]
80 Govindasamy R, Govindarasu M, Alharthi SS, Mani P, Bernaurdshaw N, Gomathi T, Ansari MA, Alomary MN, Atwah B, Malik MS, Rajeswari VD, Rekha K, Ahmed SA, Thiruvengadam M. Sustainable Green Synthesis of Yttrium Oxide (Y2O3) Nanoparticles Using Lantana camara Leaf Extracts: Physicochemical Characterization, Photocatalytic Degradation, Antibacterial, and Anticancer Potency. Nanomaterials 2022;12:2393. [DOI: 10.3390/nano12142393] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Zhang L, Yan C, Hou X, Zhang X, Xie J, Xu H, Tong Y, Cui X, Cai K, Pu X, Wang L, Bai T, Wang D. The predictive accuracy of preoperative erythrocyte count and maximum tumor diameter to maximum kidney diameter ratio in renal cell carcinoma. Transl Androl Urol 2022;11:974-81. [PMID: 35958894 DOI: 10.21037/tau-22-414] [Reference Citation Analysis]
82 Gao C, Kwong CH, Wang Q, Kam H, Wei J, Chen Q, Zhang J, Lee SM, Gu D, Wang R. Surface-engineered chlorella alleviated hypoxic tumor microenvironment for enhanced chemotherapy and immunotherapy of first-line drugs. Materials Today 2022. [DOI: 10.1016/j.mattod.2022.06.024] [Reference Citation Analysis]
83 Mafi AR, Ghanbari Motlagh A, Azadeh P. The Impact of COVID-19 on Cancer Recurrence: A Narrative Review. Arch Iran Med 2022;25:450-455. [DOI: 10.34172/aim.2022.74] [Reference Citation Analysis]
84 Guda MR, Tsung AJ, Asuthkar S, Velpula KK. Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism. Cell Death Dis 2022;13:574. [PMID: 35773253 DOI: 10.1038/s41419-022-05024-z] [Reference Citation Analysis]
85 Arora L, Kalia M, Dasgupta S, Singh N, Verma AK, Pal D. Development of a Multicellular 3D Tumor Model to Study Cellular Heterogeneity and Plasticity in NSCLC Tumor Microenvironment. Front Oncol 2022;12:881207. [DOI: 10.3389/fonc.2022.881207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Stella GM, Scialò F, Bortolotto C, Agustoni F, Sanci V, Saddi J, Casali L, Corsico AG, Bianco A. Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review. Cancers 2022;14:3131. [DOI: 10.3390/cancers14133131] [Reference Citation Analysis]
87 Lam KH, Ma S. Noncellular components in the liver cancer stem cell niche: Biology and potential clinical implications. Hepatology 2022. [PMID: 35727189 DOI: 10.1002/hep.32629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
88 Wang C, Tang Y, Ma H, Wei S, Hu X, Zhao L, Wang G. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Front Genet 2022;13:919389. [DOI: 10.3389/fgene.2022.919389] [Reference Citation Analysis]
89 Shinde VR, Revi N, Murugappan S, Singh SP, Rengan AK. Enhanced Permeability and Retention Effect: A key facilitator for solid tumor targeting by nanoparticles. Photodiagnosis Photodyn Ther 2022;:102915. [PMID: 35597441 DOI: 10.1016/j.pdpdt.2022.102915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Pang Z, Gu MD, Tang T. Pseudomonas aeruginosa in Cancer Therapy: Current Knowledge, Challenges and Future Perspectives. Front Oncol 2022;12:891187. [PMID: 35574361 DOI: 10.3389/fonc.2022.891187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Aramini B, Masciale V, Arienti C, Dominici M, Stella F, Martinelli G, Fabbri F. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers 2022;14:2408. [DOI: 10.3390/cancers14102408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Majewska A, Brodaczewska K, Filipiak-duliban A, Kajdasz A, Kieda C. miRNA Pattern in Hypoxic Microenvironment of Kidney Cancer—Role of PTEN. Biomolecules 2022;12:686. [DOI: 10.3390/biom12050686] [Reference Citation Analysis]
93 Lee S, Kim Y, Lee ES. Hypoxia-Responsive Azobenzene-Linked Hyaluronate Dot Particles for Photodynamic Tumor Therapy. Pharmaceutics 2022;14:928. [DOI: 10.3390/pharmaceutics14050928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ghosh A, Ghosh AK, Chowdhury M, Das PK. Folic Acid-Functionalized Carbon Dot-Enabled Starvation Therapy in Synergism with Paclitaxel against Breast Cancer. ACS Appl Bio Mater 2022. [PMID: 35452214 DOI: 10.1021/acsabm.2c00235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
96 Gusev E, Zhuravleva Y. Inflammation: A New Look at an Old Problem. Int J Mol Sci 2022;23:4596. [PMID: 35562986 DOI: 10.3390/ijms23094596] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
97 Goldenson BH, Hor P, Kaufman DS. iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting. Front Immunol 2022;13:841107. [PMID: 35185932 DOI: 10.3389/fimmu.2022.841107] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
98 Leitner BP, Siebel S, Akingbesote ND, Zhang X, Perry RJ. Insulin and cancer: a tangled web. Biochem J 2022;479:583-607. [PMID: 35244142 DOI: 10.1042/BCJ20210134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Liu Y, Chen S, Cai K, Zheng D, Zhu C, Li L, Wang F, He Z, Yu C, Sun C. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis. Cell Death Dis 2022;13:232. [PMID: 35283481 DOI: 10.1038/s41419-022-04669-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
100 Shen W, Han G, Yu L, Yang S, Li X, Zhang W, Pei P. Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis. IJN 2022;Volume 17:1397-408. [DOI: 10.2147/ijn.s359156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Huang X, Hao J, Tan Y, Zhu T, Pandey V, Lobie PE. CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives. IJMS 2022;23:2642. [DOI: 10.3390/ijms23052642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
102 Valente O, Messina R, Ingravallo G, Bellitti E, Zimatore DS, de Gennaro L, Abbrescia P, Pati R, Palazzo C, Nicchia GP, Trojano M, Signorelli F, Frigeri A. Alteration of the translational readthrough isoform AQP4ex induces redistribution and downregulation of AQP4 in human glioblastoma. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04123-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
103 Shariatzadeh S, Moghimi N, Khalafi F, Shafiee S, Mehrabi M, Ilkhani S, Tosan F, Nakhaei P, Alizadeh A, Varma RS, Taheri M. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; A New Horizon. Front Bioeng Biotechnol 2022;10:847433. [DOI: 10.3389/fbioe.2022.847433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
104 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
105 Bouhamida E, Morciano G, Perrone M, Kahsay AE, Della Sala M, Wieckowski MR, Fiorica F, Pinton P, Giorgi C, Patergnani S. The Interplay of Hypoxia Signaling on Mitochondrial Dysfunction and Inflammation in Cardiovascular Diseases and Cancer: From Molecular Mechanisms to Therapeutic Approaches. Biology (Basel) 2022;11:300. [PMID: 35205167 DOI: 10.3390/biology11020300] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 El-Banna MA, Hendawy OM, El-Nekeety AA, Abdel-Wahhab MA. Efficacy of ginsenoside Rg3 nanoparticles against Ehrlich solid tumor growth in mice. Environ Sci Pollut Res Int 2022. [PMID: 35118592 DOI: 10.1007/s11356-022-19019-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Peng J, Liang Q, Xu Z, Cai Y, Peng B, Li J, Zhang W, Kang F, Hong Q, Yan Y, Zhang M. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses. Front Immunol 2021;12:813747. [PMID: 35095909 DOI: 10.3389/fimmu.2021.813747] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
108 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
109 Rado M, Flepisi B, Fisher D. The Effect of Normoxic and Hypoxic U-87 Glioblastoma Paracrine Secretion on the Modulation of Brain Endothelial Cells. Cells 2022;11:276. [DOI: 10.3390/cells11020276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
110 Mahalanobis S, Apoorva, Sharma N, Luthra R, Menon T, Das A. Cancer prognosis and immune system. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00004-3] [Reference Citation Analysis]
111 Mir MA, Naik AQ. Breast cancer stem cells and their role in tumor microenvironment. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies 2022. [DOI: 10.1016/b978-0-443-18696-7.00005-1] [Reference Citation Analysis]
112 Andreucci E, Peppicelli S, Ruzzolini J, Bianchini F, Calorini L. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry. Cancer Metastasis Rev 2022;41:935-51. [PMID: 36224457 DOI: 10.1007/s10555-022-10067-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Augustine TN. The Immunomodulatory and Hemostatic Role of Platelets in Cancer. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_64-1] [Reference Citation Analysis]
114 Kumon K, Afify SM, Hassan G, Ueno S, Monzur S, Nawara HM, Quora HAA, Sheta M, Xu Y, Fu X, Zahra MH, Seno A, Seno M. Differentiation of cancer stem cells into erythroblasts in the presence of CoCl2. Sci Rep 2021;11:23977. [PMID: 34907219 DOI: 10.1038/s41598-021-03298-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
115 Rado M, Flepisi B, Fisher D. Differential Effects of Normoxic versus Hypoxic Derived Breast Cancer Paracrine Factors on Brain Endothelial Cells. Biology (Basel) 2021;10:1238. [PMID: 34943153 DOI: 10.3390/biology10121238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
116 Savanur MA, Weinstein-Marom H, Gross G. Implementing Logic Gates for Safer Immunotherapy of Cancer. Front Immunol 2021;12:780399. [PMID: 34804073 DOI: 10.3389/fimmu.2021.780399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
117 Tan NKW, Yap DWT, Tan BKJ, Teo YH, Tan EKH, Chan JY, Lee HY, See A, Toh ST. The association of obstructive sleep apnea with melanoma incidence and mortality: a meta-analysis of 5,276,451 patients. Sleep Med 2021;88:213-20. [PMID: 34794048 DOI: 10.1016/j.sleep.2021.10.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Bouleftour W, Rowinski E, Louati S, Sotton S, Wozny AS, Moreno-Acosta P, Mery B, Rodriguez-Lafrasse C, Magne N. A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy. Med Sci Monit 2021;27:e934116. [PMID: 34728593 DOI: 10.12659/MSM.934116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
119 Rakotomalala A, Escande A, Furlan A, Meignan S, Lartigau E. Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of Radiotherapy. Front Endocrinol (Lausanne) 2021;12:742215. [PMID: 34539584 DOI: 10.3389/fendo.2021.742215] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
120 Horst EN, Bregenzer ME, Mehta P, Snyder CS, Repetto T, Yang-Hartwich Y, Mehta G. Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model. Acta Biomater 2021;132:401-20. [PMID: 33940195 DOI: 10.1016/j.actbio.2021.04.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
121 Marongiu L, Allgayer H. Viruses in colorectal cancer. Mol Oncol 2021. [PMID: 34514694 DOI: 10.1002/1878-0261.13100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Saber S, Nasr M, Saad AS, Mourad AAE, Gobba NA, Shata A, Hafez AM, Elsergany RN, Elagamy HI, El-Ahwany E, Amin NA, Girgis S, Elewa YHA, Mahmoud MH, Batiha GE, El-Rous MA, Kamal I, Kaddah MMY, Khodir AE. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression. Biomed Pharmacother 2021;142:112029. [PMID: 34416629 DOI: 10.1016/j.biopha.2021.112029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
123 Tagliazucchi GM, Wiecek AJ, Withnell E, Secrier M. Genomic and local microenvironment effects shaping epithelial-to-mesenchymal trajectories in cancer.. [DOI: 10.1101/2021.07.23.453584] [Reference Citation Analysis]
124 Gastelum G, Veena M, Lyons K, Lamb C, Jacobs N, Yamada A, Baibussinov A, Sarafyan M, Shamis R, Kraut J, Frost P. Can Targeting Hypoxia-Mediated Acidification of the Bone Marrow Microenvironment Kill Myeloma Tumor Cells? Front Oncol 2021;11:703878. [PMID: 34350119 DOI: 10.3389/fonc.2021.703878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
125 Huang CH, Chong KY, Lei KF. Analysis of the Internal Hypoxic Environment in Solid Tumor Tissue Using a Folding Paper System. ACS Appl Mater Interfaces 2021;13:33885-93. [PMID: 34259499 DOI: 10.1021/acsami.1c08857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
126 Mortezaee K. Normalization in tumor ecosystem: Opportunities and challenges. Cell Biol Int 2021. [PMID: 34189798 DOI: 10.1002/cbin.11655] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
127 Zhang H, Steed A, Co M, Chen X. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resist 2021;4:684-709. [PMID: 34322664 DOI: 10.20517/cdr.2021.32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
128 Mokhtari RB, Qorri B, Sambi M, Baluch N, Kumar S, Das B, Szewczuk MR, Yeger H, Cheng HM. 3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model. Cancers (Basel) 2021;13:2784. [PMID: 34205080 DOI: 10.3390/cancers13112784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
129 Lee HW, Jose CC, Cuddapah S. Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases. Semin Cancer Biol 2021:S1044-579X(21)00150-4. [PMID: 34058338 DOI: 10.1016/j.semcancer.2021.05.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
130 Pakravan N, Abbasi A, Hassan ZM. Immunotherapy Using Oxygenated Water and Tumor-Derived Exosomes Potentiates Antitumor Immune Response and Attenuates Malignancy Tendency in Mice Model of Breast Cancer. Oxid Med Cell Longev 2021;2021:5529484. [PMID: 34194604 DOI: 10.1155/2021/5529484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
131 Zhang Y, Yang F, Peng X, Li X, Luo N, Zhu W, Fu M, Li Q, Hu G. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment. Front Cell Dev Biol 2021;9:665364. [PMID: 33959617 DOI: 10.3389/fcell.2021.665364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
132 Guo K, Feng Y, Zheng X, Sun L, Wasan HS, Ruan S, Shen M. Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors. Front Oncol 2021;11:644134. [PMID: 33937049 DOI: 10.3389/fonc.2021.644134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
133 Verges S, Chambellan A. [Altitude: A unique model for understanding the effects of hypoxia]. Rev Mal Respir 2021;38:331-3. [PMID: 33931168 DOI: 10.1016/j.rmr.2021.03.009] [Reference Citation Analysis]
134 Bharti A, Urs AB, Kumar P. Significance of HIF-1α Expression and LOXL-2 Localization in Progression of Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2021;22:341-7. [PMID: 33639646 DOI: 10.31557/APJCP.2021.22.2.341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
135 Uddin F, Hoque M. Non-flavonoids Targeting Cancer Stem Cells: A Promising Therapeutic Avenue for Cancer Treatment. Polyphenols-based Nanotherapeutics for Cancer Management 2021. [DOI: 10.1007/978-981-16-4935-6_8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]